Clinical Trials Directory

Trials / Sponsors / Shanghai Yunying Medical Technology

Shanghai Yunying Medical Technology

Industry · 8 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors
Osteosarcoma, Sarcoma, Soft Tissue Sarcoma
EARLY_Phase 12023-07-12
RecruitingA Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors
Sarcoma, Carcinoma, Digestive Cancer
EARLY_Phase 12023-06-24
RecruitingA Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Ti
Osteosarcoma, Sarcoma, Sarcoma,Soft Tissue
EARLY_Phase 12023-04-10
UnknownA Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid T
Lung Cancer, Bronchial Cancer, Non Small Cell Lung Cancer
EARLY_Phase 12023-03-30
UnknownA Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck
Head and Neck Cancer, Esophageal Cancer, Otorhinolaryngologic Neoplasms
EARLY_Phase 12023-03-27
UnknownA Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors
Sarcoma, Carcinoma, Breast Cancer
EARLY_Phase 12023-03-02
UnknownA Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and End
Cervical Cancer, Endometrial Cancer, Advanced Cancer
EARLY_Phase 12023-02-06
UnknownA Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Ovarian Cancer
Ovarian Cancer, Peritoneal Carcinomatosis, Fallopian Tube Cancer
EARLY_Phase 12022-12-02